Adma Biologics | ADMA - Beneficio Operativo

Precio De Mercado
8.27
Cambio Diario
-0.23 -2.71%
Mensual
-23.00%
Anual
-58.00%
Q2 Expectativa
8.10




Beneficio Operativo Cambio Fecha
Adma Biologics USD 62.75M 11.74M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Novavax USD 20.94M 100.32M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Takeda JPY -13.62B 182.44B 2026-03